VTYX   $14.0  0.14% Market Closed

Ventyx Biosciences, Inc.
Total Cash 239.44M
totalCashPerShare 3.388
EBITDA -185.55M
Total Debt 11.27M
quickRatio 13.253
currentRatio 14.192
Total Revenue
debtToEquity 4.012
Revenue/Share
ROA -0.35294
ROE -0.56294
grossProfits
freeCashflow -94.25M
operatingCashflow -158.48M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -63.51M
forwardPE -1.0495495
floatShares 49.68M
sharesOutstanding 70.67M
sharesShort 8.38M
sharesShortPriorMonth 8.60M
dateShortInterest
sharesPercentSharesOut 0.12%
heldPercentInsiders 0.03%
heldPercentInstitutions 0.92%
Short Ratio help_outline 5.56%
shortPercentOfFloat 0.14%
impliedSharesOutstanding
bookValue 3.974
Price To Book help_outline 0.59
earningsQuarterlyGrowth
netIncomeToCommon -171.30M
trailingEps -2.96%
forwardEps -2.22%
enterpriseToEbitda 0.34
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.52 3Q 2024
institutionsCount 164
lastUpdated Nov. 7, 2024, 6:57 a.m.